Nestle DHA, ARA Infant Formula Claims Must Be “Compositional” – NAD
This article was originally published in The Tan Sheet
Executive Summary
Nestle may continue to make "limited" claims regarding DHA and ARA in advertising for its Good Start Supreme DHA & ARA infant formula, according to the National Advertising Division
You may also be interested in...
Similac Advance Immune Development Claims Upheld By NAD
Claims touting Ross Products' Similac Advance infant formula's effect on immune system development fall short of implying it protects the immune system as effectively as breast milk, the National Advertising Division concludes in a recent review
Enfamil/Similac Compositional Comparisons Should Be Revised – NAD
Mead Johnson should discontinue or modify compositional comparisons made between its Enfamil LIPIL and Ross Products' Similac Advance infant formulas, according to the National Advertising Division
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC